Is neoadjuvant radiation associated with improved survival in patients with resectable pancreatic cancer : an analysis of data from the surveillance , epidemiology , and end results ( SEER ) registry?
This analysis of SEER data showed a survival benefit for the use of neoadjuvant RT over surgery alone or surgery with adjuvant RT in treating pancreatic cancer. Therapeutic strategies that use neoadjuvant RT should be further explored for patients with resectable pancreatic cancer.
Self-efficacy explains the influence of social support and depression on treatment adherence and may be a key target for interventions to improve disease management and self-care behaviors in HF patients.